These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 3299984)
1. Mutant insulin syndrome: identification of two families with [LeuA3]insulin and determination of its biological activity. Nanjo K; Sanke T; Kondo M; Nishimura S; Miyano M; Linuma J; Miyamura K; Inouye K; Given BD; Polonsky KS Trans Assoc Am Physicians; 1986; 99():132-42. PubMed ID: 3299984 [No Abstract] [Full Text] [Related]
2. Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). Clinical and functional characteristics of [LeuA3] insulin. Nanjo K; Sanke T; Miyano M; Okai K; Sowa R; Kondo M; Nishimura S; Iwo K; Miyamura K; Given BD J Clin Invest; 1986 Feb; 77(2):514-9. PubMed ID: 3511099 [TBL] [Abstract][Full Text] [Related]
3. Receptor binding and negative cooperativity of a mutant insulin, [LeuA3]-insulin. Kobayashi M; Takata Y; Ishibashi O; Sasaoka T; Iwasaki TM; Shigeta Y; Inouye K Biochem Biophys Res Commun; 1986 May; 137(1):250-7. PubMed ID: 3521604 [TBL] [Abstract][Full Text] [Related]
5. Studies of insulin receptor binding and insulin action in humans. Pedersen O Dan Med Bull; 1984 Feb; 31(1):1-32. PubMed ID: 6365475 [No Abstract] [Full Text] [Related]
6. [Insulin resistance in type 2 diabetes. Receptor and post-receptor aspects]. Purrello F; Trischitta V; Vigneri R Minerva Endocrinol; 1984; 9(2):221-8. PubMed ID: 6390135 [No Abstract] [Full Text] [Related]
7. Preparation and biological properties of [LeuB24, LeuB25]human insulin. Jonczyk A; Keefer LM; Naithani VK; Gattner HG; De Meyts P; Zahn H Hoppe Seylers Z Physiol Chem; 1981 May; 362(5):557-61. PubMed ID: 7019034 [No Abstract] [Full Text] [Related]
8. [Pyruvate kinase activity as a marker of erythrocyte age increases the reliability of the method of determining insulin binding to membrane receptors]. Klimes I; Zórad S; Svábová E; Ficková M; Sorocinová E; Macho L Vnitr Lek; 1987 Jun; 33(6):454-63. PubMed ID: 3310385 [No Abstract] [Full Text] [Related]
9. SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway. Cliffe ST; Kramer JM; Hussain K; Robben JH; de Jong EK; de Brouwer AP; Nibbeling E; Kamsteeg EJ; Wong M; Prendiville J; James C; Padidela R; Becknell C; van Bokhoven H; Deen PM; Hennekam RC; Lindeman R; Schenck A; Roscioli T; Buckley MF Hum Mol Genet; 2009 Jun; 18(12):2257-65. PubMed ID: 19336477 [TBL] [Abstract][Full Text] [Related]
10. [Insulin receptors of adipose tissue in patients newly diagnosed with insulin-dependent diabetes mellitus]. Evdokimova NIu; Efimov AS; Bezdrobnyĭ IuV Vopr Med Khim; 1985; 31(2):64-8. PubMed ID: 3890366 [TBL] [Abstract][Full Text] [Related]
11. [Insulin-receptor interaction of plasma membranes of liver cells and isolated adipocytes of the rat with different insulin content in the blood]. Liubarskaia SG; Gracheva NK; Kniazeva AP; Starosel'tseva LK Biokhimiia; 1980 Aug; 45(8):1517-23. PubMed ID: 7016200 [TBL] [Abstract][Full Text] [Related]
13. Studies of relationships between variation of the human G protein-coupled receptor 40 Gene and Type 2 diabetes and insulin release. Hamid YH; Vissing H; Holst B; Urhammer SA; Pyke C; Hansen SK; Glümer C; Borch-Johnsen K; Jørgensen T; Schwartz TW; Pedersen O; Hansen T Diabet Med; 2005 Jan; 22(1):74-80. PubMed ID: 15606695 [TBL] [Abstract][Full Text] [Related]
14. [Review for clinical molecular genetics of mutant insulin]. Sanke T; Nanjo K Nihon Rinsho; 1994 Oct; 52(10):2550-5. PubMed ID: 7983776 [TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of insulin Lispro in 2 patients with type II diabetes mellitus. Jehle PM; Fussgänger RD; Seibold A; Lüttke B; Böhm BO Int J Clin Pharmacol Ther; 1996 Nov; 34(11):498-503. PubMed ID: 8937933 [TBL] [Abstract][Full Text] [Related]
16. Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes. Molven A; Ringdal M; Nordbø AM; Raeder H; Støy J; Lipkind GM; Steiner DF; Philipson LH; Bergmann I; Aarskog D; Undlien DE; Joner G; Søvik O; ; Bell GI; Njølstad PR Diabetes; 2008 Apr; 57(4):1131-5. PubMed ID: 18192540 [TBL] [Abstract][Full Text] [Related]
17. Identification of a single nucleotide polymorphism showing no insulin-mediated suppression of the promoter activity in the human insulin receptor substrate 2 gene. Iwamoto K; Mori H; Okazawa H; Hashiramoto M; Kasuga M Diabetologia; 2002 Aug; 45(8):1182-95. PubMed ID: 12189449 [TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the insulin gene among Japanese subjects. Oda N; Nakai A; Fujiwara K; Imamura S; Fujita T; Hamagishi M; Kato T; Kobayashi T; Himeno Y; Yamamoto K; Makino M; Kakizawa H; Sawai Y; Itoh M; Nagasaka A Metabolism; 2001 Jun; 50(6):631-4. PubMed ID: 11398136 [TBL] [Abstract][Full Text] [Related]
19. [Genetic abnormalities in the insulin receptor in non-insulin-dependent diabetes]. Capeau J; Desbois C; Magré J Journ Annu Diabetol Hotel Dieu; 1993; ():37-50. PubMed ID: 8331874 [No Abstract] [Full Text] [Related]
20. Human insulin receptor substrate-1: variant sequences in familial non-insulin-dependent diabetes mellitus. Armstrong M; Haldane F; Taylor RW; Humphriss D; Berrish T; Stewart MW; Turnbull DM; Alberti KG; Walker M Diabet Med; 1996 Feb; 13(2):133-8. PubMed ID: 8641117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]